Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Distler

Showing results (301-310 of 621) with videos related to

Pageof 63
Sort By:
Annals of the Rheumatic Diseases|March 10, 2012
Inhibition of hedgehog signalling prevents experimental fibrosis and induces regression of established fibrosisAngelika Horn, Trayana Kireva, Katrin Palumbo-Zerr, et al.
Clinical and Experimental Rheumatology|September 5, 2015
Autopsy versus clinical findings in patients with systemic sclerosis in a case series from patients of the EUSTAR databaseBettina Sandmeier, Veronika K Jäger, Gabriella Nagy, et al.
Journal of Scleroderma and Related Disorders|October 10, 2022
Diagnosis and monitoring of systemic sclerosis-associated interstitial lung disease using high-resolution computed tomographyDinesh Khanna, Oliver Distler, Vincent Cottin, et al.
Journal of Scleroderma and Related Disorders|April 6, 2022
Prediction of organ involvement and survival in systemic sclerosis patients in the first 5 years from diagnosisWieneke Mt van den Hombergh, Hanneke Ka Knaapen-Hans, Frank Hj van den Hoogen, et al.
Cells|September 14, 2024
The Expression of Toll-like Receptors in Cartilage Endplate Cells: A Role of Toll-like Receptor 2 in Pro-Inflammatory and Pro-Catabolic Gene ExpressionTamara Mengis, Laura Bernhard, Andrea Nüesch, et al.
Arthritis Research|November 28, 2002
Angiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcersOliver Distler, Angela Del Rosso, Roberto Giacomelli, et al.
Arthritis and Rheumatism|May 1, 2009
Histone deacetylase 7, a potential target for the antifibrotic treatment of systemic sclerosisHossein Hemmatazad, Hanna Maciejewska Rodrigues, Britta Maurer, et al.
JACC. Cardiovascular Imaging|July 22, 2019
Clinical and Echocardiographic Associates of All-Cause Mortality and Cardiovascular Outcomes in Patients With Systemic SclerosisSuzanne E van Wijngaarden, Maaike Boonstra, Bas Bloem, et al.
Annals of the Rheumatic Diseases|August 24, 2012
Inhibition of H3K27 histone trimethylation activates fibroblasts and induces fibrosisMarlene Krämer, Clara Dees, Jingang Huang, et al.
Science Signaling|September 4, 2014
Oxidative DNA damage induces the ATM-mediated transcriptional suppression of the Wnt inhibitor WIF-1 in systemic sclerosis and fibrosisSilvia Svegliati, Giusi Marrone, Antonio Pezone, et al.
Pageof 63

Showing results (301-310 of 621) with videos related to

Sort By:
Pageof 63
Annals of the Rheumatic Diseases|March 10, 2012
Inhibition of hedgehog signalling prevents experimental fibrosis and induces regression of established fibrosisAngelika Horn, Trayana Kireva, Katrin Palumbo-Zerr, et al.
Clinical and Experimental Rheumatology|September 5, 2015
Autopsy versus clinical findings in patients with systemic sclerosis in a case series from patients of the EUSTAR databaseBettina Sandmeier, Veronika K Jäger, Gabriella Nagy, et al.
Journal of Scleroderma and Related Disorders|October 10, 2022
Diagnosis and monitoring of systemic sclerosis-associated interstitial lung disease using high-resolution computed tomographyDinesh Khanna, Oliver Distler, Vincent Cottin, et al.
Journal of Scleroderma and Related Disorders|April 6, 2022
Prediction of organ involvement and survival in systemic sclerosis patients in the first 5 years from diagnosisWieneke Mt van den Hombergh, Hanneke Ka Knaapen-Hans, Frank Hj van den Hoogen, et al.
Cells|September 14, 2024
The Expression of Toll-like Receptors in Cartilage Endplate Cells: A Role of Toll-like Receptor 2 in Pro-Inflammatory and Pro-Catabolic Gene ExpressionTamara Mengis, Laura Bernhard, Andrea Nüesch, et al.
Arthritis Research|November 28, 2002
Angiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcersOliver Distler, Angela Del Rosso, Roberto Giacomelli, et al.
Arthritis and Rheumatism|May 1, 2009
Histone deacetylase 7, a potential target for the antifibrotic treatment of systemic sclerosisHossein Hemmatazad, Hanna Maciejewska Rodrigues, Britta Maurer, et al.
JACC. Cardiovascular Imaging|July 22, 2019
Clinical and Echocardiographic Associates of All-Cause Mortality and Cardiovascular Outcomes in Patients With Systemic SclerosisSuzanne E van Wijngaarden, Maaike Boonstra, Bas Bloem, et al.
Annals of the Rheumatic Diseases|August 24, 2012
Inhibition of H3K27 histone trimethylation activates fibroblasts and induces fibrosisMarlene Krämer, Clara Dees, Jingang Huang, et al.
Science Signaling|September 4, 2014
Oxidative DNA damage induces the ATM-mediated transcriptional suppression of the Wnt inhibitor WIF-1 in systemic sclerosis and fibrosisSilvia Svegliati, Giusi Marrone, Antonio Pezone, et al.
Pageof 63